NCT00323635View on ClinicalTrials.gov

A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause.

PHASE4TerminatedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

April 30, 2006

Primary Completion Date

January 31, 2010

Study Completion Date

January 31, 2011

Conditions
Urinary Incontinence
Interventions
DRUG

tolterodine

tablet, 4 mg, daily, 1 month

Trial Locations (2)

02114

Massachusetts General Hospital, Boston

02120

Brigham & Women's Hospital, Boston

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Brigham and Women's Hospital

OTHER